May 8 (Bloomberg) -- Sun Pharmaceutical Industries Ltd.,
India’s largest drugmaker by market value, is recalling almost
400,000 bottles of anti-depressant and antihistamine medications
in the U.S. because the pills failed to dissolve properly.

The recall is the latest in a string by Indian companies
that has led to increased scrutiny from regulators concerned
that the quality of drugs made in that country aren’t up to U.S.
standards. The concerns prompted Margaret Hamburg, the
commissioner of the U.S. Food and Drug Administration, to go to
India in February to meet with pharmaceutical makers there about
production quality.

About 128,000 bottles of Sun Pharma’s Cetirizine, the
antihistamine, “may not meet the drug release specification
through expiry,” the FDA said in a statement. The 252,000
bottles of generic Effexor, called Venlafaxine, for depression
being recalled are distributed by Sun’s U.S. arm, Caraco
Pharmaceutical Laboratories Ltd., and are manufactured in
Gujarat, India.